Theoretical study on some non-selective beta-adrenergic antagonists and correlation to their biologically active configurations

[1]  S. Pourbeyram,et al.  New Insights on the Mechanism of Thermal Cleavage of Unsaturated Bicyclic Diaziridines: A DFT Study , 2011 .

[2]  Sattar,et al.  Theoretical Study of Halogen Effect in Isomerization of 2-Halo-[9]-annulen Anion at the DFT Level , 2011 .

[3]  S. Morishima,et al.  Pharmacological evaluation of ocular beta-adrenoceptors in rabbit by tissue segment binding method. , 2009, Life sciences.

[4]  U. Kompella,et al.  Cassette analysis of eight beta-blockers in bovine eye sclera, choroid-RPE, retina, and vitreous by liquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  Sid Topiol,et al.  Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery. , 2008, Bioorganic & medicinal chemistry letters.

[6]  M. Z. Kassaee,et al.  Reaction of Aspirin with Fecapentaene-12: A Possibility for Aspirin to Make Fecapentaene-12 Lose its Mutagenecity , 2008 .

[7]  S. Arshadi,et al.  Conformational Analysis, Infrared, and Fluorescence Spectra of 1-Phenyl-1,2-propandione 1-oxime and Related Tautomers: Experimental and Theoretical Study , 2007 .

[8]  Jillian G. Baker,et al.  The selectivity of β‐adrenoceptor antagonists at the human β1, β2 and β3 adrenoceptors , 2005 .

[9]  J. Baker.  The selectivity of b -adrenoceptor antagonists at the human b 1, b 2 and b 3 adrenoceptors , 2005 .

[10]  Carol Smith,et al.  Beta-Blocker Selectivity at Cloned Human Beta1- and Beta2-Adrenergic Receptors , 1999, Cardiovascular Drugs and Therapy.

[11]  D. Brocks,et al.  Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[12]  J. Dobrowolski,et al.  On the conformation of the propranolol molecule , 2000 .

[13]  K. Stoschitzky,et al.  Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies. , 1993, Chirality.

[14]  T. Walle,et al.  A stereoselective central hypotensive action of atenolol. , 1989, The Journal of pharmacology and experimental therapeutics.

[15]  J. Nathanson.  Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process. , 1988, The Journal of pharmacology and experimental therapeutics.

[16]  B. Waldeck,et al.  Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of terbutaline and pindolol. , 2009, Acta pharmacologica et toxicologica.

[17]  H. Ammon,et al.  The crystal structures of dichloroisoproterenol, propranolol and propranolol hydrochloride , 1977 .

[18]  A. Barrett,et al.  The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias , 1968, British journal of pharmacology.